Top Markets
#1 ADO Protocol ADO Protocol +329.35%
#2 GoPlus Security GoPlus Security +55.37%
#3 Starpower Starpower +43.14%
#4 Nockchain Nockchain +37.40%
#5 Verus Coin Verus Coin +33.47%
#6 Tutorial Tutorial +32.97%
#7 GAIB AID GAIB AID +24.67%
#8 The Black Bull The Black Bull +21.49%
#9 Chainflip Chainflip +21.21%
#10 peaq peaq +17.62%
Coin of the day
ADO Protocol ADO Protocol
Settings
Language
ENGLISH
Currency
USD
Theme
Lunai Bioworks Inc. Lunai Bioworks Inc.

Lunai Bioworks Inc.

LNAI
Rank in Stocks #32427
Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to... Lunai Bioworks Inc. (LNAI), formerly operating as Renovaro, is now dedicated to leveraging artificial intelligence for the creation of advanced medical treatments and the strengthening of biological defense systems. A significant project currently underway is the development of its specialized "Neurotoxicity Intelligence Technology."
Share Price
$2.24
Market Cap
$10.13M
Change (1 day)
0.68%
Change (1 year)
-
Country
US
Trade Lunai Bioworks Inc. (LNAI)

Category

Healthcare
Revenue for Lunai Bioworks Inc. (LNAI)
Revenue in Aug 2026 TTM: 0
According to Lunai Bioworks Inc. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Lunai Bioworks Inc. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $10.11B -
BE